人福医药集团股份公司2025年度权益分派实施公告详解

证券代码：600079
证券简称：ST人福
公告编号：2026-063
公告日期：2026年7月25日

一、公告要点与分红详情

• 每股现金红利：0.48元（含税）
• 分红总额：783,468,463.20元
• 基准总股本：1,632,225,965股
• 差异化分红送转：否

二、关键日期

三、分红实施办法与税务处理

• 派发对象：截至股权登记日收市后，在中国结算上海分公司登记在册的全体股东。
• 分红方式：除公司自行发放的对象外，其余股东的现金红利由中国结算上海分公司通过资金清算系统向已办理指定交易的股东派发。未办理指定交易的股东红利暂由中国结算上海分公司保管，待办理后再派发。
• 自行发放对象：中粮信托有限责任公司－中粮信托－春泥1号破产重整服务信托、招商生命科技（武汉）有限公司、招商生科投资发展（武汉）合伙企业（有限合伙）、李杰、陈小清，现金红利由公司直接发放。
• 税务处理：
  • 自然人股东及证券投资基金：根据持股期限差异化征收个人所得税。持股超1年免税，1个月以内全额计入应纳税所得额，1个月至1年减半计入。税率均为20%，公司暂不扣税，转让股票时由结算公司扣税。
  • QFII股东：公司按10%税率代扣代缴企业所得税，实发每股0.432元。可自行向税务机关申请协定待遇退税。
  • 香港市场投资者：同样按10%税率代扣代缴，实发每股0.432元。其他国家税收居民可申请协定待遇。
  • 其他机构投资者和法人股东：公司不代扣企业所得税，需自行申报，实发税前每股0.48元。

四、对投资者的影响与重要提醒

• 分红金额较大：公司本次现金分红总额达到7.83亿元，显示公司经营状况良好，盈利能力强，或将提振市场信心并提升股价。
• 分红政策明确：分红方案已于2026年6月5日经年度股东大会审议通过，具有法律效力，分红时间和税务政策清晰，为投资者提供稳定预期。
• 税务差异需注意：不同股东类型的税务处理不同，特别是自然人股东需根据持股期限在股票转让时缴税，QFII和港股投资者则由公司代扣。
• 除权日与红利发放日一致：2026年8月3日为除权日和现金红利实际发放日，投资者在此日期前持股可享受分红。

五、咨询与联系方式

如有疑问，可咨询公司董事会办公室：
电话：027-87597232

免责声明

本报道仅为信息披露与投资参考，不构成任何投资建议。投资者需根据自身情况和市场变化进行决策，分红方案与税务政策如有变动请以公司正式公告为准。投资有风险，入市需谨慎。

Detailed Analysis: Renfu Pharmaceutical Group Co., Ltd. 2025 Dividend Distribution Implementation Announcement

Stock Code: 600079
Stock Abbreviation: ST Renfu
Announcement Number: 2026-063
Announcement Date: July 25, 2026

1. Key Points & Dividend Details

• Cash Dividend per Share: RMB 0.48 (pre-tax)
• Total Dividend Amount: RMB 783,468,463.20
• Total Shares: 1,632,225,965
• Differentiated Dividend Distribution: No

2. Important Dates

3. Implementation & Tax Treatment

• Eligible Shareholders: All shareholders registered at China Securities Depository and Clearing Shanghai Branch as of the record date.
• Distribution Method: Cash dividends will be distributed through the clearing system for shareholders who have completed designated transactions. Undesignated shareholders’ dividends will be temporarily held until designation is completed.
• Direct Payment: Dividends for certain shareholders (including CITIC Trust – Chun Ni No.1 Bankruptcy Restructuring Service Trust, China Merchants Life Science (Wuhan) Co., Ltd., China Merchants Biology Investment Development (Wuhan) Partnership, Li Jie, and Chen Xiaoqing) will be paid directly by the company.
• Tax Treatment:
  • Individual Shareholders & Funds: Tax is based on holding period. Over 1 year: tax exempt. Within 1 month: full taxed at 20%. 1 month to 1 year: half taxed. Tax is withheld upon stock transfer, not dividend payout.
  • QFII Shareholders: 10% corporate tax withheld; net dividend is RMB 0.432 per share. Can apply for tax treaty benefits.
  • HK Market Investors: 10% tax withheld; net dividend is RMB 0.432 per share. Other country tax residents may apply for treaty benefits.
  • Other Institutional and Corporate Shareholders: No withholding; shareholders self-report, pre-tax RMB 0.48 per share paid.

4. Impact & Investor Reminders

• Substantial Dividend: The total dividend payout of RMB 783 million signals strong financial performance, likely boosting investor confidence and potentially affecting share price positively.
• Dividend Policy Clarity: The plan was approved at the annual shareholders meeting on June 5, 2026, providing legal certainty and clear schedule for investors.
• Tax Treatment Differences: Investors need to pay attention to tax policies based on their holding period and shareholder type, especially for individuals and overseas investors.
• Ex-dividend Date & Payment Date: Both are August 3, 2026. Investors holding shares before this date are eligible for the dividend.

5. Contact Information

For inquiries, contact the Board of Directors Office:
Phone: 027-87597232

Disclaimer

This report is for information disclosure and investment reference only and does not constitute investment advice. Investors should make decisions based on their own circumstances and market changes. Please refer to official company announcements for any changes. Investing involves risks; please proceed with caution.

View ST人福 Historical chart here